IGFBP-rp1/IGFBP-7 ELISA DY1334-05 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemIGFBP-rp1/IGFBP-7 ELISA
CompanyR&D Systems, a Bio-Techne Brand
Price $450.00Supplier Page View Company Product Page
Catalog NumberDY1334-05
Quantity1 Kit (for 5 Plates)
ApplicationsELISA
Detection Range39.10 - 2500 pg/mL
ReactivityHuman
Detection TargetIGFBP-rp1/IGFBP-7
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
NCBI Full Gene Nameinsulin like growth factor binding protein 7
NCBI Gene AliasesAGM, FSTL2, IBP-7, IGFBP-7, IGFBP-7v, IGFBPRP1, MAC25, PSF, RAMSVPS, TAF

Specifications/Features

Available conjugates: Sizes Available: 1 Kit (for 5 Plates)

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Renal Angina Indices and Urinary BiomarkersKidney360January 1, 2026Erick Y. Zúñiga-González, Karla I. Linares-Robles, Juan M. Villegas-Gamas, Noemí Del Toro-Cisneros, Cristino Cruz-Rivera, María José López-Ruelas, Rosario G. Hernández-Ortega, Pablo Galindo, Yazmin A. Mercado-Hernández, Olynka Vega-Vegabinding protein 7 (IGFBP7), tissue inhibitor of metalloproteinase-2 (TIMP-2; DY1757, DY1578, DKM100, DY1334-05, DY971, R&D Systems), and heat shock protein 72 (MBS705388, MyBioSource). Assays were validated in triplicate

(2) Renal Angina Indices and Urinary Biomarkers: A Combined Approach to Predict Acute Kidney Injury in Critically Ill PatientsKidney360November 12, 2025Erick Y. Zúñiga-González, Karla I. Linares-Robles, Juan M. Villegas-Gamas, Noemí Del Toro-Cisneros, Cristino Cruz-Rivera, María José López-Ruelas, Rosario G. Hernández-Ortega, Pablo Galindo, Yazmin A. Mercado-Hernández, Olynka Vega-Vegabinding protein 7 (IGFBP7), tissue inhibitor of metalloproteinase-2 (TIMP-2; DY1757, DY1578, DKM100, DY1334-05, DY971, R&D Systems), and heat shock protein 72 (MBS705388, MyBioSource). Assays were validated in triplicate

(3) Mitochondrial oxygenation monitoring and acute kidney injury risk in cardiac surgery: A prospective cohort studyJournal of clinical anesthesiaFebruary 1, 2025de Wijs CJ, Streng LWJM, Stolker RJ, Ter Horst M, Hoorn EJ, Mahtab EAF, Mik EG, Harms FA.

(4) Urinary biomarkers for diagnosing acute kidney injury in sepsis in the emergency departmentHeliyonJanuary 15, 2025Baek S, Park I, Kim S, Um YW, Kim HE, Lee K, Lee JH, Jo YH.

(5) Tubular Injury Biomarkers to Predict CKD and Hypertension at 3 Months Post-Cisplatin in ChildrenKidney360June 1, 2024Ryan S. Huang, Kelly R. McMahon, Stella Wang, Hayton Chui, Asaf Lebel, Jasmine Lee, Vedran Cockovski, Shahrad Rod Rassekh, Kirk R. Schultz, Tom D. Blydt-Hansen, et al.kits (NGAL ELISA Kit 036, Bioporto, Grusbakken, Denmark; KIM-1, TIMP-2, IGFBP-7: Duoset DY1750. DY971, DY1334-05; R&D Systems, Inc., MN) using manufacturer's instructions.23,24 Inter and intra-assay coefficients of

(6) Tubular Injury Biomarkers to Predict CKD and Hypertension at 3 Months Post-Cisplatin in ChildrenKidney360April 26, 2024Ryan S. Huang, Kelly R. McMahon, Stella Wang, Hayton Chui, Asaf Lebel, Jasmine Lee, Vedran Cockovski, Shahrad Rod Rassekh, Kirk R. Schultz, Tom D. Blydt-Hansen, et al.kits (NGAL ELISA Kit 036, Bioporto, Grusbakken, Denmark; KIM-1, TIMP-2, IGFBP-7: Duoset DY1750. DY971, DY1334-05; R&D Systems, Inc., MN) using manufacturer's instructions.23,24 Inter and intra-assay coefficients of

(7) Serum Insulin-Like Growth Factor-Binding Protein 7 Deriving from Spleen and Lung Could Be Used for Early Recognition of Cardiac Surgery-Associated Acute Kidney InjuryCardiorenal MedicineAugust 8, 2023Yimei Wang, Bo Shena, Xuesen Cao, Zhihui Lu, Yang Zhang, Bowen Zhu, Weidong Zhang, Yiqin Shi, Jialin Wang, Yi Fang, et al.levels were measured in plasma using commercially available ELISAs (Human IGFBP7-rp1/IGFBP7, R&D System, DY1334-05), Ancillary Reagent Kit 3 (R&D System, DY009), and Human TIMP2 (R&D System, DTM200) at presurgery, 0

(8) Crosstalk between Cancer Cells and Cancer-Associated Fibroblasts Mediated by TGF-β1-IGFBP7 Signaling Promotes the Progression of Infiltrative Gastric CancerCancersAugust 4, 2023Hong Z, Xie W, Zhuo H, Wei X, Wang K, Cheng J, Lin L, Hou J, Chen X, Cai J.

(9) Recombinant Alpha-1-Microglobulin (RMC-035) to Prevent Acute Kidney Injury in Cardiac Surgery Patients: Phase 1b Evaluation of Safety and PharmacokineticsKidney International ReportsMay 1, 2023Raphael Weiss, Melanie Meersch, Carola Wempe, Thilo von Groote, Tobias Agervald, Alexander Zarbockmetalloproteinases-2 (TIMP-2, DTM200 Quantikine), and insulin-like growth factor binding protein 7 (IGFBP7, DY1334-05 DuoSet) were analyzed by validated commercially available enzyme-linked immunosorbent assay (R&D Systems. Inc

(10) Remote ischemic preconditioning causes transient cell cycle arrest and renal protection by a NF-κB-dependent Sema5B pathwayJCI insightJuly 22, 2022Rossaint J, Meersch M, Thomas K, Mersmann S, Lehmann M, Skupski J, Tekath T, Rosenberger P, Kellum JA, Pavenstädt H, et al.

(11) Derivation and validation of urinary TIMP-1 for the prediction of acute kidney injury and mortality in critically ill childrenJournal of translational medicineFebruary 23, 2022Huang H, Lin Q, Dai X, Chen J, Bai Z, Li X, Fang F, Li Y.determined. Human Lipocalin 2/NGAL (ab113326, Abcam, USA), TIMP-2 (DY971, R&D Systems, USA) and IGFBP7 (DY1334-05, R&D Systems, USA) ELISA kits were used for the measurement of NGAL, TIMP-2 and IGFBP7 in urine. In

(12) Urine Biomarkers for the Assessment of Acute Kidney Injury in Neonates with Hypoxic Ischemic Encephalopathy Receiving Therapeutic HypothermiaThe Journal of pediatricsFebruary 1, 2022Rumpel J, Spray BJ, Chock VY, Kirkley MJ, Slagle CL, Frymoyer A, Cho SH, Gist KM, Blaszak R, Poindexter B, et al.

(13) Combining renal cell arrest and damage biomarkers to predict progressive AKI in patient with sepsisBMC nephrologyDecember 15, 2021Tao X, Chen C, Luo W, Zhou J, Tian J, Yang X, Hou FF.TIMP-2*IGFBP7 (u[TIMP-2]*[IGFBP7]), were measured by ELISA kits (TIMP-2: DTM200, R&D Systems; IGFBP7: DY1334-05, R&D Systems) according to the manufacturer’s instructions. The levels of renal cell injury and inflammation

(14) The Biomarker TCONS_00016233 Drives Septic AKI by Targeting the miR-22-3p/AIFM1 Signaling AxisMolecular therapy. Nucleic acidsMarch 6, 2020Zhang P, Yi L, Qu S, Dai J, Li X, Liu B, Li H, Ai K, Zheng P, Qiu S, et al.An ELISA kit for IL-1β (ab100562), TNF-α (ab181421), TIMP-2 (Cat. No. DTM200), and IGFBP7 (Cat. No. DY1334-05) was purchased from R&D Systems (Minneapolis, MN, USA). Cell Culture and Treatments HK-2 cells were

(15) Urinary mitochondrial DNA copy number identifies renal mitochondrial injury in renovascular hypertensive patients undergoing renal revascularization: A Pilot StudyActa Physiol (Oxf)July 1, 2019Alfonso Eirin, Sandra M. Herrmann, Ahmed Saad, Abdelrhman Abumoawad, Hui Tang, Amir Lerman, Stephen C. Textor, Lilach O. LermanCat# K002-H1). Author Manuscript IGFBP-7 and TIMP-2 were measured by ELISA (R&D systems, Cat no. KIT DY1334–05 and Sigma-Aldrich, lot no. RAB0472, respectively) and their product (IGFBP-7 × TIMP-2) calculated. Changes

(16) Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill childrenBMC pediatricsJune 15, 2018Bai Z, Fang F, Xu Z, Lu C, Wang X, Chen J, Pan J, Wang J, Li Y.facilitate the calculation for urinary FGF23/urinary Cr ratios. The human IGFBP-rp1/IGFBP-7 ELISA kit (DY1334–05, R&D Systems, USA) was used for the measurement. The samples were diluted 20-fold to 100-fold in Reagent

(17) Urinary Matrix Metalloproteinase-7 Predicts Severe AKI and Poor Outcomes after Cardiac SurgeryJournal of the American Society of NephrologyNovember 1, 2017Xiaobing Yang, Chunbo Chen, Siyuan Teng, Xiaorui Fu, Yan Zha, Huafeng Liu, Li Wang, Jianwei Tian, Xiangyan Zhang, Youhua Liu, et al.to the manufacturer’s instructions. u[TIMP-2]z[IGFBP7] levels were tested by ELISA kit (DTM200 and DY1334–05; R&D Systems). The NEPHROCHECK for TIMP-2 and IGFBP7 measuring approved by the US FDA was not available

(18) Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients with Atherosclerotic Renal Artery StenosisCirc Cardiovasc IntervSeptember 1, 2017Ahmed Saad, Sandra M.S. Herrmann, Alfonso Eirin, Christopher M. Ferguson, James F Glockner, Haraldur Bjarnason, Michael A McKusick, Sanjay Misra, Lilach O. Lerman, Stephen C. TextorDKM100, respectively).The samples for IGFBP-7 were diluted 1:2 and tested by ELISA (R&D systems, Cat# KIT DY1334–05). The samples for TIMP-2 were diluted 1:500 and tested by ELISA (SIGNA-ALDRICH, lot # RAB0472). Levels

(19) Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery StenosisCirculation: Cardiovascular InterventionsSeptember 1, 2017Ahmed Saad, Sandra M.S. Herrmann, Alfonso Eirin, Christopher M. Ferguson, James F. Glockner, Haraldur Bjarnason, Michael A. McKusick, Sanjay Misra, Lilach O. Lerman, Stephen C. TextorDKM100, respectively).The samples for IGFBP-7 were diluted 1:2 and tested by ELISA (R&D systems, Cat no. KIT DY1334-05). The samples for TIMP-2 were diluted 1:500 and tested by ELISA (Sigma-Aldrich, lot no. RAB0472). Levels

Be the First to Write a Review!

IGFBP-rp1/IGFBP-7 ELISA

Human IGFBP-rp1/IGFBP-7 DuoSet ELISA

IGFBP-rp1/IGFBP-7 ELISA from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (19)

Reviews

IGFBP-rp1/IGFBP-7 ELISA from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map